Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7PO7

Phosphoglycolate phosphatase from Mus musculus

Summary for 7PO7
Entry DOI10.2210/pdb7po7/pdb
DescriptorGlycerol-3-phosphate phosphatase, ACETATE ION, SULFATE ION, ... (6 entities in total)
Functional Keywordspgp, glycerol-3-phosphate phosphatase, aum, apo-enzyme, hydrolase
Biological sourceMus musculus (Mouse)
Total number of polymer chains8
Total formula weight279146.82
Authors
Schloetzer, J.,Schindelin, H.,Fratz, S. (deposition date: 2021-09-08, release date: 2022-12-21, Last modification date: 2024-10-23)
Primary citationJeanclos, E.,Schlotzer, J.,Hadamek, K.,Yuan-Chen, N.,Alwahsh, M.,Hollmann, R.,Fratz, S.,Yesilyurt-Gerhards, D.,Frankenbach, T.,Engelmann, D.,Keller, A.,Kaestner, A.,Schmitz, W.,Neuenschwander, M.,Hergenroder, R.,Sotriffer, C.,von Kries, J.P.,Schindelin, H.,Gohla, A.
Glycolytic flux control by drugging phosphoglycolate phosphatase.
Nat Commun, 13:6845-6845, 2022
Cited by
PubMed Abstract: Targeting the intrinsic metabolism of immune or tumor cells is a therapeutic strategy in autoimmunity, chronic inflammation or cancer. Metabolite repair enzymes may represent an alternative target class for selective metabolic inhibition, but pharmacological tools to test this concept are needed. Here, we demonstrate that phosphoglycolate phosphatase (PGP), a prototypical metabolite repair enzyme in glycolysis, is a pharmacologically actionable target. Using a combination of small molecule screening, protein crystallography, molecular dynamics simulations and NMR metabolomics, we discover and analyze a compound (CP1) that inhibits PGP with high selectivity and submicromolar potency. CP1 locks the phosphatase in a catalytically inactive conformation, dampens glycolytic flux, and phenocopies effects of cellular PGP-deficiency. This study provides key insights into effective and precise PGP targeting, at the same time validating an allosteric approach to control glycolysis that could advance discoveries of innovative therapeutic candidates.
PubMed: 36369173
DOI: 10.1038/s41467-022-34228-2
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.31 Å)
Structure validation

227344

数据于2024-11-13公开中

PDB statisticsPDBj update infoContact PDBjnumon